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After intraperitoneal injection of mice with infectious, inactivated, or envelope
preparations of the elementary body of Chlamydia psittaci, lymphocyte transfor-
mation of spleen cells to the mitogens concanavalin A, phytohemagglutinin, and
lipopolysaccharide was significantly reduced 1 and 2 weeks postinjection. Lym-
phocyte response returned to the control values by 4 weeks. Similarly, transfor-
mation of cells by chlamydial antigen was not detected until 4 weeks post-
injection. Injection of the noninfectious intracellular reticulate body, in contrast,
had little effect on transformation of cells to concanavalin A. When control spleen
cells were incubated with infectious or inactivated elementary bodies in vitro,
response to all three mitogens was also reduced. The sooner the organisms were
added after the addition of mitogen, the greater the reduction in transformation.
Incubation with elementary body envelopes and reticulate bodies had no effect on
lymphocyte transformation of the spleen cells to concanavalin A. The relationship
between the observed ability to reduce the response in the in vitro assay of
lymphocyte transformation and the actual in vivo establishment of infection is
discussed.
Chlamydiae are obligate intracellular bacteria
that are responsible for a number of disease
syndromes, including trachoma, sexually trans-
mitted diseases, and psittacosis (9, 27, 31). Cell-
mediated and humoral immune responses to the
chlamydiae have been recorded after infection in
humans and in a variety of animal models (10,
14, 23-25, 36). Despite such responses, chronic
or latent infections are the general rule after
primary infection. Vaccines and passive transfer
of immunity, in general, have not provided solid
immunity against challenge (3, 7, 21, 24).
The interactions of the chlamydiae with host
cells are very specific. These organisms are able
to induce their own uptake into nonprofessional
phagocytic cells and subsequently to circumvent
phagolysosome fusion and multiply in the cells
(6, 37). The multiplication cycle involves two
distinct forms of the microorganism: the elemen-
tary body (EB), which is the infectious extracel-
lular form, and the reticulate body (RB), which
is the metabolically active, highly permeable
intracellular form.
It has been demonstrated that many microor-
ganisms modulate the host immune response
during or after infection (29, 30). This is one way
in which the balance of host and microorganism
can be affected. We have examined whether
infection with chlamydiae can result in such a
modulation of the host immune response. Chla-
mydia psittaci infection in mice provides a suit-
able model for such studies. Mice that recover
from primary infection are resistant to subse-
quent challenge with a lethal dose of inoculum.
However, successful recovery does not denote
sterile immunity, and chlamydiae can be isolated
from these mice (4, 26). Using lymphocyte trans-
formation as our assay system, we have found
that, after in vivo injection of infectious or
inactivated C. psittaci or in vitro incubation with
the microorganisms, [3H]thymidine incorpo-
ration in mitogen-stimulated spleen cells is de-
pressed. The contribution of such a modulation
of host cell response to the establishment of a
latent or persistent infection is discussed.
(A preliminary report was presented at the
80th Annual Meeting of the American Society of
Microbiology in Miami Beach, Fla., 11 to 16
May 1980.)
MATERIAULS AND METHODS
Animals. Female F1 mice (C57BIJ6 x C3H) were
obtained from Cumberland View Farms, Clinton,
Tenn., and used at between 8 and 12 weeks of age.
Mice were screened for the presence of preexisting
chlamydia-neutralizing antibody by testing for the
ability of serum to inhibit the formation of inclusions in
L cells. Attempts were also made to grow chlamydiae
out of the spleens and livers of untreated or hydrocor-
tisone-treated mice. Tests were negative for the pres-
ence of chlamydiae or neutralizing antibody before
injection. After injection with C. psittaci, mice were
maintained in an isolation cubicle in the animal facili-
ty.
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Experimental infection. Intraperitoneal infection of
mice with C. psittaci has been well characterized (4,
26). Injection of high concentrations of infectious EBs
(2 x 108 cells per mouse) causes toxemia-type death in
mice within 24 h, whereas injection of a moderate
concentration (1 x 108 cells per mouse) results in an
infectious syndrome with death occurring at between 2
and 7 days postinjection. Injection of lower concentra-
tions results in a latent form of the infection, and
organisms have been grown out for as long as 7 months
postinjection. In these studies mice were infected
intraperitoneally with 7 x 10' infectious organisms. At
1 month postinfection, small numbers of chlamydiae
could be grown out of the spleen when spleen cell
suspensions were cocultivated with L cells. Control
mice were injected with uninfected L-cell material
processed in the same manner as the chlamydia-
infected cells.
Growth and purification of EBs and RBs. The CallO
meningopneumonitis strain of C. psittaci was grown in
929 L-cell suspension cultures by the method of Ta-
mura and Higashi (32). The L cells were free of
mycoplasma contamination (courtesy of Wallace
Clyde, Department of Pediatrics, University of North
Carolina School of Medicine). The EBs were harvest-
ed and purified as previously reported (38). Briefly,
cell-free supernatants from infected suspension L-cell
cultures were harvested at 48 h postinfection and then
subjected to differential centrifugation, followed by
centrifugation through 30% sucrose cushions and dis-
continuous gradients of 38, 44, and 599o Renografin-76
(E. R. Squibb & Sons, Inc., Princeton, N.J.). Infectiv-
ity was assayed by the inclusion-forming unit tech-
nique (13). The RBs were grown and purified by the
technique of Brownridge and Wyrick (5). The RBs are
not infectious, so they cannot be titrated by the
inclusion-forming unit technique. Protein in the puri-
fied RBs was determined by the Lowry assay.
Inactivation of C. psi#aci with heat, UV light, and
immune serum. Purified EBs were treated with UV
light by the procedure of Byrne (6). For heat treat-
ment, the EBs were suspended in phosphate-buffered
saline (PBS) and incubated in a 56°C water bath for 30
min. Infectivity after treatment was assayed by the
inclusion-forming unit technique, and more than 99%o
of the infectious particles were inactivated.
Antiserum to C. psittaci was prepared by repeated
intravenous injection of New Zealand white rabbits
with purified EBs of the CallO strain. Antiserum was
ammonium sulfate precipitated, dialyzed, and stored
at -70°C. When a 1/10 dilution of antiserum was
incubated with EBs (2 x 109) at a 1:1 ratio for 30 min
at 37°C, greater than 99%o neutralization of infectivity
was observed.
EB envelope preparation. EB envelopes were pre-
pared by a modification of the method ofTamura et al.
(33). Purified EBs were suspended in PBS without
Ca2e and Mg2", sonicated for 90 s at 40 kc/s (model
W140 Sonifier, Heat Systems-Ultrasonics, Inc., Plain-
view, Long Island, New York), and incubated with 20
,ug of trypsin (Worthington Diagnostics, Freehold,
N.J.) per ml for 15 min at 37°C, followed by addition of
trypsin inhibitor. The EBs were disrupted by use of a
Mickle apparatus at 60 cycles per s at 4°C for 10 min.
The disrupted material was centrifuged to remove dust
and beads, sonicated, and then treated with DNase
and RNase (100 ,ug of each per ml) for 30 min at 37°C.
This was followed by a second trypsin treatment. The
envelope material was sonicated, layered on a linear
sucrose gradient (5 to 45%), and centrifuged for 30 mi
at 6,000 rpm in the SW25 rotor of a Spinco ultracentri-
fuge. The envelope band was collected, washed, and
suspended in PBS without Mg2" and Ca2". Envelopes
were frozen at -70°C until used. Envelopes were
enumerated by direct particle count, and 2 x 109 EB
envelopes contained 35 ,ug of protein.
Lymphocyte transformation. (i) In vivo infection with
C. psiffaci. Mice were infected intraperitoneally with
infectious, inactivated, or envelope preparations of C.
psittaci. The spleens were subsequently harvested,
and cells were teased from the spleens, washed several
times, and suspended in RPMI 1640 containing 10o
heat-inactivated fetal bovine serum (KC Biological,
Lenexa, Kans.) at a concentration of 5 x 106 cells per
ml. Cells were dispensed in 0.1-ml portions into the
wells of 96-well flat-bottomed microtiter plates (Fal-
con Plastics, Oxnard, Calif.). A 0.1-ml portion of
mitogen in medium was added to each well, and plates
were incubated at 37°C in a humidified incubator with
5% CO2. After 48 h, 0.5 ,uCi of [3H]thymidine (specific
activity, 1.9 Ci/mmol; Schwarz/Mann, Orangeburg,
N.Y. in 20 ,ul of RPMI 1640 was added to each well,
followed by an additional 10-h incubation period.
Cultures were harvested with a Mash II automatic
harvester, placed in Econofluor (New England Nucle-
ar Corp., Boston, Mass.), and counted in a Packard
liquid scintillation counter. In preliminary studies, the
following optimal mitogen concentrations were deter-
mined: concanavalin A (ConA), 0.2 ,ug per well;
phytohemagglutinin (PHA), 1 ,ug per well; lipopolysac-
charide (LPS; Sigma Chemical Co., St. Louis, Mo.), 5
p.g per well. Optimal incubation times were also deter-
mined (see below). All cultures were performed in
triplicate, and standard deviations were generally less
than 10o. All experiments were repeated a minimum
of three times with different batches of purified chla-
mydiae. Representative experiments are presented
because the extent of the decrease varied depending
on the individual preparation of chlamydiae used for
injection or for in vitro addition. In most studies,
spleens from four or more mice were pooled for each
injection group.
When transformation to chlamydial antigen was
tested, erythrocytes were removed from cell suspen-
sions by treatment with 0.83% NH4CI and then cells
and antigen were incubated together for 5 days in
RPMI 1640 containing 10-5 M 2-mercaptoethanol
(Eastman Organic Chemicals, Rochester, N.Y.). Cells
were subsequently pulsed with [3H]thymidine for 24 h
and harvested as described above. Chlamydial antigen
consisted of purified EBs that had been UV inactivat-
ed and stored at -70°C until used. At a protein
concentration of 0.3 FJg per well (1.5 ,ug/ml), transfor-
mation of responding spleen cells to chlamydial anti-
gen was optimal.
(U) In vitro incubation ofchlamydiae with spleen ceils.
Spleens were removed from untreated mice, and cell
suspensions were prepared as described above except
that erythrocytes were first removed by treating the
cells with 0.83% NH4Cl. Infectious, inactivated, or
envelope preparations of chlamydiae were added to
spleen cells at a ratio of 100:1 or 10:1 and incubated at
37°C for 1.5 h with rotation. The preparations were
then dispensed into microtiter plates, and mitogen was
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added. Preliminary studies indicated no difference in
the degree of reduction of lymphocyte transformation
if the remaining chlamydiae were removed by washing
after the 1.5-h incubation period or allowed to remain
for the entire 58 h. The ability of the chlamydiae to
bind mitogen was tested by incubating ConA with
chlamydiae and subsequently removing the chlamyd-
iae. The treated ConA was able to induce transforma-
tion of spleen cells to the same extent as the untreated
ConA. To eliminate the possibility that any decrease in
mitogen response was caused by simple disruption of
normal cell-cell interaction due to the presence of the
chlamydiae, control spleen cell cultures (no chlamyd-
iae added) contained an equivalent amount of protein
from sonicated L cells.
(iii) Mouse serum. Infected and control mice were
bled by cardiac puncture. The serum was removed
from clotted blood, heat inactivated, and sterilized by
passage through a 0.22-,um membrane filter (Millipore
Corp., Bedford, Mass.). Fresh serum or serum stored
at -20°C was diluted 1/10 and used instead of fetal
bovine serum in the lymphocyte transformation assay
with spleen cells from uninjected mice.
(iv) Macrocultures. For supernatant exchange and
delayed in vitro addition of chlamydiae, spleen cells
were prepared as described above, and 1 ml of 2 x 106
cells per ml was added to plastic tubes (12 by 75 mm;
no. 2001; Falcon Plastics). ConA was added to the
cultures at a concentration of 1.5 ,ug per culture. For
harvesting, 3 ml ofPBS was added to each culture, and
the cultures were blended in a Vortex mixer and
collected on glass fiber filter disks (Reeve-Angel,
Clifton, N.J.) with suction. Filters were then washed
once with 5% trichloroacetic acid and three times with
PBS, dried, and counted in the scintillation counter.
Immunofluorescent staining of spleen cells. Mouse
spleen cells were characterized by their surface mark-
ers. Spleen cell suspensions were washed, pelleted,
and then resuspended with 0.5 ml of a 1/20 dilution of
rabbit anti-mouse thymocyte serum (Cappel Labora-
tories, Downingtown, Pa.), rabbit anti-mouse
immunoglobulin serum (Cappel), or normal rabbit se-
rum. Cells were incubated for 30 min at room tempera-
ture, then washed three times, resuspended in the
fluorescein-conjugated immunoglobulin gG fraction of
goat anti-rabbit serum (Cappel), and incubated for 30
min at room temperature. Cells were washed again
three times and examined with a Leitz fluorescent
microscope. A total of 300 cells were counted per
slide, and the numbers represent the mean of three
experiments. The specificity of the commercial anti-
sera was tested and confirmed before use.
T-cell enrichment. Spleen cell preparations were
enriched for the presence of T cells by using the
column adherence method of Julius et al. (12). Nylon
wool was washed to remove toxic products and dried,
and 0.6 g was added to each 10-ml plastic syringe.
Autoclaved syringes were preincubated with RPMI
1640 for 45 min at 37°C before the addition of cells.
Cells were prepared as follows. A total of 108 spleen
cells were incubated in a 100-mm plastic petri plate for
1 h at 37°C. Nonadherent cells were then removed by
gentle agitation, added to a second petri plate, and
incubated for an additional 1 h. Nonadherent cells
were then added to nylon wool columns and incubated
for 45 min at 37°C, and the first 20 ml of effluent was
collected. Recovery after nylon wool passage ranged
from 20 to 30%o. Adherent cells were removed from the
first petri plate with a rubber policeman and used as
the source of adherent cells in additional experiments.
Statistics. In all experiments, numbers represent the
mean of triplicate cultures. Standard deviations were
generally less than 10%o. Differences in lymphocyte
responses were analyzed by Student's t test. Results
for which P - 0.05 were defined as not significant.
RESULTS
In vivo injection of C. psiutaci. Initial studies were
performed to determine whether infection of
mice with chlamydiae had any effect on the
ability of host cells to respond to mitogen. Mice
were injected intrapentoneally with 7 x 107
infectious EBs per mouse. The infected mice
showed no outward signs or symptoms of infec-
tion; however, splenomegaly of varying duration
was observed for up to 2 months postinfection.
Spleen cells from infected mice sacrificed 1 and
2 weeks postinfection exhibited reduced
[3H]thymidine uptake relative to control cells
when they were incubated with the T-cell mito-
gens ConA and PHA and the B-cell mitogen LPS
(Fig. 1). At 4 weeks postinfection, the uptake
had returned to control values. In repeated
studies it was observed that although the pattern
remained consistent, the extent of the decrease
and the length of time before the response
returned to normal varied depending on the
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FIG. 1. Mitogen responsiveness of spleen cells from mice infected with C. psittaci. Mice were injected
intraperitoneally with 7 x 107 infectious EBs and sacrificed at the indicated intervals. Net 103 cpm = 103 cpm for
cells with mitogen - 103 cpm for cells with medium. At 1 and 2 weeks postinfection, the difference in response
between control and test animals was significant at P c 0.001 to 0.01.
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TABLE 1. Spleen cells assayed by indirect
immunofluorescence for theta and immunoglobulina
Spleen % Theta % Immuno-
cells positive globulin % Nullpositive
Control' 35.0 ± 1.0 35.9 ± 1.7 29.2 ± 2.7
EB 39.6 ± 0.4 36.1 ± 2.5 24.3 ± 2.7
a A total of 300 cells were counted per slide, and the
numbers represent the mean of three experiments ±
standard deviation. Null cells are cells that did not
stain with either the anti-theta antisera or the anti-
immunoglobulin antisera.
b Mice were injected intraperitoneally with 7 x 10'
infectious EBs (EB) or with L-cell material (control),
and spleens were harvested at 2 weeks postinfection.
individual preparation of chlamydiae used for
injection. The decrease in [3H]thymidine uptake
was not due to a decrease in cell viability during
culture or during exposure to [3H]thymidine, as
monitored by the trypan blue exclusion tech-
nique. The mean cell count, as measured by
[3H]thymidine uptake for the unstimulated cul-
tures, also showed little variation in cells from
infected and control animals. The difference was
not caused by a shift in the sensitivity of the cells
from infected mice to the optimal mitogen con-
centration or a shift in the time of maximal
response of the cells to the mitogen. The pres-
ence of splenomegaly did not correlate with the
decrease in mitogen response, and the spleens
remained enlarged after the mitogen response
had returned to control levels. It was possible
that the population of cell types within the
spleen was altered during infection, resulting in
a depletion in the number of transformable cells.
However, no difference was observed in the
percentage of T and B cells found in control and
infected spleens as determined by indirect im-
munofluorescence (Table 1).
The ability of spleen cells from infected mice
to respond to chlamydial antigen was also tested
(Table 2). With the exception of day 3, postin-
fection transformation to the specific antigen
was not observed, in spleen cells from infected
mice during the first 2 weeks, which correlates
with the observed decrease in transformation
when cells were incubated with mitogen. At 4
weeks postinfection, there was a significant re-
sponse of infected cells to chlamydial antigen.
In some infections (20, 35) it has been found
that mitogen or antigen responses, or both, can
be modulated by serum factors. Fresh or frozen
serum from infected mice sacrificed at the stated
time intervals did not have a suppressive effect
on mitogen-induced transformation when added
to spleen cells from untreated mice.
It was of interest to determine whether the
reduction in uptake of [3H]thymidine after incu-
bation with mitogen was a function of the infec-
tious process or caused by the mere presence of
the chlamydiae. Three preparations of nonviable
chlamydiae were used for injections: UV- or
heat-treated EBs or EB envelopes. UV-treated
EBs retain the ability to induce their own uptake
and evade phagolysosome fusion in nonprofes-
sional phagocytic cells, whereas heat-treated
organisms lose these functions (6, 37, 38). It is
not known whether envelopes can inhibit phago-
lysosome fusion or be taken up by nonprofes-
sional phagocytes such as L cells. As observed
at 2 weeks postinjection with infectious EBs,
transformation of spleen cells by the test mito-
gen was reduced after injection of the threee
nonviable preparations (Fig. 2). The degree of
reduction did not seem to be strongly dependent
on the concentration of chlamydiae injected, as
103 infectious EBs were as effective as 108 were.
Incubation of chlamydiae with neutralizing anti-
body in vitro leads to rapid uptake and degrada-
tion of the microorganisms when incubated with
macrophages (37, 38). When infectious chlamyd-
iae were incubated with neutralizing antibody in
vitro and subsequently injected into mice, a
reduction in lymphocyte transformation was still
observed (Table 3).
These findings suggest that a degradation
product of the cell envelope may be responsible
for the reduced lymphocyte transformation. It
was therefore of interest to test whether injec-
tion of the RB, which has lost some of the rigid
components found in the envelope of the EB and
lacks a number of virulence determinants (5, 18,
33), would have a similar effect on lymphocyte
transformation. Injection of RBs, at concentra-
tions up to 10 times that of EBs, did not have an
effect on the ability of spleen cells from the
TABLE 2. Transformation of mouse spleen cells by chlamydial antigena
Spleen Net 103 cpm + SD at day postinjection:
cells 1 3 5 7 9 11 14 28
EB 1.2 + 0.16 9.5 ± 1.3 1.9 ± 0.57 0.8 ± 0.16 3.5 ± 0.63 1.6 ± 0.58 1.3 ± 0.29 43 ± 3.5
Control 2.9 ± 0.4 0.9 ± 0.19 3.3 ± 0.30 1.1 ± 0.53 2.9 ± 0.52 1.2 ± 0.53 1.9 ± 0.4 3.4 ± 0.79
a Mice were infected with 7 x 107 infectious EBs (EB) or L-cell material (control), spleen cells were harvested
at the indicated days postinjection, and the response to EB antigen or medium was recorded. Net 103 cpm = 103
cpm with ConA - 103 cpm with medium.
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FIG. 2. Mitogen responsiveness of spleen cells from mice injected with treated or infectious C. psittaci. Mice
were injected with 108, 105, or 103 infectious EBs, 108 UV-treated (UV) or heat-treated (A) EBs, 10 ,ug EB
envelopes (E), or with L-cell material (C). Spleens were harvested at 2 weeks postinjection. P - 0.001 to 0.01.
injected mice to be transformed by ConA (Table
4). The component responsible for the decrease
in lymphocyte transformation is apparently
found on the infectious extracellular EB but not
on the noninfectious intracellular RB.
To determine whether the decrease in lym-
phocyte transformation was due to the produc-
tion of suppressor substances during in vitro
incubation or conversely to the inability to pro-
duce the soluble signals necessary for transfor-
mation, medium exchange was performed be-
tween cultures of control and EB spleen cells at
various times after the addition of mitogen (Ta-
ble 5). It is clear that the medium exchange had
no effect on the ability of either cell type to
respond to the mitogen ConA. The role that
macrophages might play in this decrease in
response was tested by depleting spleen cells of
macrophages via adherence and subsequently
TABLE 3. ConA response of spleen cells from mice
injected with antibody-neutralized C. psittacia
ConA response
Injected with: (net 103 cpmb pc
± SD)
Preimmune + EB 56.1 ± 6.0 <0.001
Immune A + EB 44.5 ± 1.4 <0.001
Immune B + EB 53.7 ± 6.3 <0.001
Preimmune + L cell 108.8 ± 14.7
a Infectious EBs were incubated for 30 min at 37°C
with preimmune serum or immune serum (batch A or
B) before injection in mice. This resulted in greater
than 99% neutralization of infectivity when tested for
the appearance of inclusions in L cells. Mice were
injected with 7 x 107 neutralized EBs or L-cell materi-
al, and spleens were harvested at 2 weeks postinjec-
tion.
b Net 103 cpm = 103 cpm with ConA - 103 cpm with
media.
c Level of significance of response relative to preim-
mune plus L-cell-injected mice, by Student's t test.
adding back these cells. It was observed (Table
6) that depletion of the macrophages decreased
the ability of the subsequent T-enriched fraction
from both control and EB spleen cells to re-
spond to ConA. The addition of EB macro-
phages to T-enriched control cells returned the
response of those cells to the level of undepleted
cells, suggesting that macrophages from EB-
injected mice are not impaired in their ability to
participate in the transformation response. The
addition of control macrophages to T-enriched
EB cells also returned the response to ConA to
the undepleted level, but it did not bring the
response to the level of the undepleted control
cells.
In vitro addition of C. psittaci to mouse spleen
cells. Infectious, UV- or heat-treated EBs were
added to spleen cells from untreated mice at EB-
to-spleen cell ratios of 100:1 and 10:1. Lympho-
cyte transformation with the three mitogens was
significantly reduced after the addition of all
three chlamydial preparations (Fig. 3). The de-
gree of reduction was dependent on the amount
of chlamydiae added, with the 100:1 ratio reduc-
TABLE 4. ConA response of spleen cells from mice
injected with the RB or EB of C. psittaci'
Injected with ConA response (net
(Ig): 103 cpmb + SD)
RB (250) 24.5 ± 2.1
RB (50) 19.6 ± 1.5
RB (25) 23.2 ± 3.0
EB (20) 7.5 ± 0.76
L cell (50) 20.9 ± 0.54
a Mice were injected intraperitoneally with 8 x 10'
infectious EBs, 20 p.g of protein per mouse, RBs, or L-
cell material at the stated concentrations. Spleens
were harvested at 2 weeks postinfection.
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TABLE 5. Effect of medium exchange on the ability of spleen cells from control and EB-infected mice to
respond to ConAa
ConA response (net 103 cpm t SD) after:
Spleen cells Medium hb 24 h 48 h
EB Control 14.3 ± 1.8 11.6 ± 1.7 14.3 ± 1.5
EB EB 16.8 ± 0.35 14.1 ± 0.86 14.4 ± 1.3
Control EB 47.1 ± 3.3 41.8 ± 4.3 45.2 ± 1.3
Control Control 40.8 ± 4.0 37.5 ± 5.4 43.2 ± 2.3
a Control and EB spleen cell culture tubes were spun at 150 x g for 10 min. Media were then exchanged
between EB and control tubes or added back to the same tube. Cultures were then gently blended in a Vortex
mixer and returned to the incubator for the remaining incubation period. Spleens were harvested at 2 weeks
postinfection.
b Time at which medium exchange occurred after the cells were put into culture.
ing transformation more effectively than the
10:1 ratio did. When the chlamydiae were re-
moved from the spleen cells by washing after the
initial incubation period and before the addition
of mitogen, lymphocyte transformation was re-
duced as effectively as when chlamydiae were
allowed to remain for the entire 58-h culture and
labeling period. Cell viability during culture or
during exposure to [3H]thymidine, as deter-
mined by trypan blue uptake, was the same in
cultures with and without added microorga-
nisms. The effect of time on the ability of C.
psittaci to reduce lymphocyte transformation
was examined by adding the EB to the cultures
at various times after the spleen cells had been
incubated with ConA. As the EB was added at
later times (Fig. 4), the response to ConA began
to approach that of the control response. Incu-
bation of cells with EB envelopes or the RB did
not cause a reduction in [3H]thymidine uptake in
response to ConA (Table 7).
DISCUSSION
The outcome of an infection ultimately de-
pends on the interaction between the infectious
agent and the immune response of the host. The
initial effect of the microorganism on the initia-
tion of the immune response may be an impor-
tant factor in the outcome, in the case of chla-
mydiae in the establishment of a latent or
persistent infection.
A generalized depression in the ability of host
cells to respond, as evidenced by the low level of
transformation to T- and B-cell mitogens and
specific chlamydial antigen, was observed after
the in vivo injection of chlamydiae. Unlike infec-
tion with such parasites as Trypanosoma congo-
lense or T. bruzei (19, 22), extensive changes in
the relative number of B, T, and null cells were
not observed. Because adherent cells from EB
spleens are capable of restoring the response of
adherent cell-depleted control cells to ConA, the
TABLE 6. Restoration of ConA response by the addition of adherent cellsa
Adherent cells added from: ConA response (net
Spleen cells EB Control 103 cpmb ± SD)
EB spleen C 12.5 ± 1.3
EB T 1.7 ± 0.25
EB T 1 x 105 10.0 ± 0.09
EB T 2.5 x 105 5.4 ± 0.85
EB T 1 x 105 12.8 ± 1.5
EB T 2.5 x 105 14.2 ± 1.4
Control spleen 40.4 ± 0.44
Control T 1.8 ± 0.14
Control T 1 x 105 53.0 ± 1.3
Control T 2.5 x 105 34.0 ± 4.1
Control T 1 x 105 41.8 ± 3.5
Control T 2.5 x 105 32.3 ± 2.4
a T-enriched spleen cells (T) were tested for the ability to respond to ConA with or without the addition of
plastic adherent cells from EB or control spleens. Each experiment used 5 x 105 spleen cells. Spleens were
harvested at 2 weeks postinfection.
b Net 103 cpm = 103 cpm with ConA - 103 cpm with media.
c , Cells not added.
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FIG. 3. Mitogen responsiveness of spleen cells after the in vitro addition of C. psittaci. Additions were as
follows: L-cell material (C), infectious EBs (EB), UV-treated EBs (UV), or heat-treated EBs (H). Chlamydiae or
L-cell material was added to spleen cells at ratios of 10:1 (labeled 1) and 100:1 (labeled 2). P c 0.01.
ability of the macrophages to perform the neces-
sary functions required for transformation, such
as the production of conditioned medium, is not
impaired (1, 2, 17). Medium exchange up to 48 h
postincubation did not affect the uptake of
[3H]thymidine by control or EB cells in response
to ConA. This eliminated the role of soluble
suppressor substances such as cold thymidine,
which is produced by the degradation of DNA
from other cells in culture by activated macro-
phages. Cocultivation experiments done with
various ratios of spleen cells from EB-injected
and control mice (data not shown) did not reveal
the presence of active suppressor cells in the EB
spleen cell suspensions.
It does not seem likely that the reduction in
lymphocyte transformation was due to the abili-
ty of the chlamydiae to block mitogen-binding
sites on the surface of the cells. Levy (15) found
that the addition of the lectin wheat germ agglu-
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FIG. 4. Addition of C. psittaci to cultures at 4, 10,
24, and 48 h after the addition of ConA. C. psittaci was
added at an EB-to-spleen cell ratio of 100:1. Percent-
age of control response to ConA = 100 x (net counts
per minute with chlamydiae added/net counts per
minute with fresh medium added).
surface of L cells, whereas the same concentra-
tion of ConA or Ricinus communis lectin causes
little inhibition of attachment. She concluded
that the attachment of chlamydiae is fairly spe-
cific for an N-acetyl-D-glucosamine-containing
receptor on the host cell. This suggests that the
binding of the chlamydiae does not block the
binding of the three mitogens tested in this
study. This observation is further supported by
the observation that increasing the concentra-
tion of ConA did not improve the response of
cells to the mitogen.
Significantly, the reduction was not a function
of the infectious process; rather, it appeared to
be due to a heat-stable component of the EB
envelope. It has been demonstrated by in vitro
studies that phagolysosome fusion does occur
when heat-treated and antibody-neutralized
chlamydiae are taken up by macrophages (37,
38). Therefore, it is possible that incomplete
degradation of the chlamydiae occurs and that a
persistent bacterial component is responsible for
the initiation of signals leading to reduced lym-
phocyte function. The persistence of cell wall
components in macrophages has been reported
for other bacteria such as group A streptococci
TABLE 7. ConA response of spleen cells incubated
in vitro with infectious EB, EB envelopes, or RB'
Addition to spleen ConA response
ceUs ~~~~~~~~(net103lls ~~~~~cpmb SD)
EB 0.8 ± 0.7
RB 29.6 ± 1.4
EB envelopes 27.4 ± 3.0
L-cell material 23.0 ± 2.5
a Concentrations of chlamydial components added:
infectious EBs = 100:1 EB-to-spleen cell ratio, 29 Fg
of protein per well; EB envelopes = 200:1, 35 gLg of
protein per well; RBs = 30 pg of protein per well; L-
cell material = 30 Fg of protein per well.
b Net 103 cpm = 103 cpm with ConA-103 cpm with
media.
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and has been associated with both the modula-
tion of the host immune response and the patho-
genesis of chronic disease (29, 30). Although
chlamydiae possess an outer membrane similar
to that of other gram-negative bacteria, they do
not have a typical peptidoglycan structure, and
the existence of a functional lipid A has not been
unequivocally demonstrated (8, 11, 16, 28);
therefore, it is possible that the responsible cell
envelope component is unique to these obligate
intracellular bacteria. The significance of re-
duced lymphocyte function during infection in
vivo is that this component is present in the
extracellular infectious form of the organism,
and more specifically in the cell envelope, but
not in the intracellular noninfectious form.
Transformation to the test mitogens was also
reduced when EBs were added directly to spleen
cells from untreated mice in vitro. However, in
contrast to the in vivo injection of EB, the
reduction observed after the in vitro addition of
EB depended on the concentration of chlamyd-
iae added and required an intact, if not viable,
organism. As the organisms were added to the
spleen cell cultures at various times after the
addition of ConA, the degree of transformation
increased, reaching near-normal levels when
added after 48 h. This indicated that the pres-
ence of the chlamydiae did not simply inhibit the
uptake of the [3H]thymidine, which was added
for the final 10 h of incubation. When unbound
chlamydiae were removed by washing after the
initial 1.5-h incubation period, lymphocyte
transformation was reduced to the same degree
as it was when the organisms were allowed to
remain for the entire culture period. Among the
possibilities suggested by these findings are that
the chlamydiae directly blocked an early step in
the transformation process and that the chla-
mydiae acted indirectly by inducing the produc-
tion of suppressor cells. Wainberg and Israel
(34) have observed a similar decrease in trans-
formation when live or UV-inactivated viruses
are coincubated with lymphocytes. Uptake is
not required because cells that lack receptors for
entry and penetration of the virus are also affect-
ed.
In their study, inhibition is nonspecific in that
membrane vesicles and pelleted material from
the supematant fluids of normal and virus-trans-
formed cells are both effective. In contrast, we
found inhibition to be specific for the extracellu-
lar form of the organism because neither L-cell
material nor RBs produced an inhibitory effect.
The micrograms of protein added in both studies
were similar, so the difference might be due to
the preparation or source of the vesicles and
supematants that they used.
The variability observed in the percent inhibi-
tion of lymphocyte transformation after the in
vivo or in vitro addition of different batches of
chlamydiae was not unexpected. In most of the
studies, the concentration of chlamydiae added
was based on the number of inclusion-forming
units of EB that were present. However, the
percent infectivity in general varied from one
purified batch to another and was generally less
than 50%. As a result, an unknown number of
noninfectious organisms were present in addi-
tion to the infectious organisms in any given
experiment. In these studies, it was found that
inactivated organisms were also capable of in-
hibiting lymphocyte transformation; therefore,
the exact number of effective organisms added
in any given experiment probably varied. The
identification and isolation of the chlamydial
envelope components responsible for the inhibi-
tion of lymphocyte transformation might help to
eliminate this variability.
The decrease observed in mitogen responsive-
ness after the in vivo injection or in vitro addi-
tion of EB is not a unique phenomenon; it has
been reported with a number of different disease
syndromes, most significantly in those that re-
sult in chronic or latent infections such as tuber-
culosis, fungal infections, and parasitic infesta-
tions. No doubt the ability of the host to respond
effectively early in the infection could be an
important factor in the establishment of a chron-
ic or latent infection. Based on our data obtained
from both in vivo and in vitro studies, we might
predict that the chlamydiae can reduce the host
response after infection in two ways. Early in
the infection, when large numbers of chlamydiae
are being released in a small area, high EB-to-
macrophage ratios exist. Cells that are not de-
stroyed by outright infection with chlamydiae
and their subsequent multiplication might be
damaged in such a way that they cannot perform
the functions necessary to initiate a specific
immune response. This would correlate with the
inhibition observed in lymphocyte transforma-
tion after in vitro incubation of EB and cells.
Later, when the host begins to respond with
antibody and activated macrophages, the persis-
tence of a partially degraded chlamydial cell wall
component may result in an additional reduction
in host immune function. The intracellular multi-
plication of chlamydiae under idealized in vitro
conditions takes from 48 to 72 h. In vivo, where
nutritional conditions are likely to be less opti-
mal, multiplication might be expected to take
even longer. The ability to reduce the host
immune response early in the infection may
allow the slow-growing chlamydiae a chance to
multiply and establish themselves intracellular-
ly, leading to a persistent infection.
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